A detailed history of Breakwater Capital Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Breakwater Capital Group holds 2,855 shares of NVO stock, worth $319,588. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,855
Previous 2,613 9.26%
Holding current value
$319,588
Previous $373 Million 8.86%
% of portfolio
0.07%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$119.07 - $145.42 $28,814 - $35,191
242 Added 9.26%
2,855 $340 Million
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $7,760 - $10,329
76 Added 3.0%
2,613 $336 Million
Q4 2023

Jan 23, 2024

BUY
$87.78 - $105.45 $33,531 - $40,281
382 Added 17.73%
2,537 $268 Million
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $195,975 - $430,008
2,155 New
2,155 $211 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Breakwater Capital Group Portfolio

Follow Breakwater Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breakwater Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Breakwater Capital Group with notifications on news.